Poorly differentiated thyroid carcinoma in a 9-year-old boy: Case report

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 9-10, 2011, Pages 783-786

  Wu, Yi Lei ^a   Ting, Wei Hsin ^a   Wey, Shiuan Li ^a   Chen, Chi Kuan ^a   Huang, Chi Yu ^a,b   Cheng, Shih Ping ^a   Lee, Yann Jinn ^a,c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

131I ablation therapy; Child; Male; Poorly differentiated thyroid carcinoma; Recombinant human TSH; Thyroid nodule

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID TRANSCRIPTION FACTOR 1; THYROXINE; TRANSCRIPTION FACTOR;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER SIZE; CANCER STAGING; CASE REPORT; CHILD; CYTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PAPILLARY CARCINOMA; SCHOOL CHILD; THYROID CARCINOMA; THYROIDECTOMY;

CELL DIFFERENTIATION; CHILD; COMBINED MODALITY THERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; THYROTROPIN;

EID: 80054055250     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2011.209     Document Type: Article

References (29)

1. Kirkland RT, Kirkland JL, Rosenberg HS, Harberg FJ, Librik L, et al. Solitary thyroid nodules in 30 children and report of a child with a thyroid abscess. Pediatrics 1973;51:85-90.
2. Blair JC. Endocrine neoplasia in childhood. In: Brook CG, Clayton PE, Brown RS, eds. Brook's clinical pediatric endocrinology, 6th Ed. Oxford: Wiley-Blackwell, 2009:428-57.
3. Niedziela M. Pathogenesis, diagnosis and management of thyroid nodules in children. Endocr Relat Cancer 2006;13:427-53. (Pubitemid 43886667)
4. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983;52:1849-55. (Pubitemid 14228153)
5. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans'" wuchernde Struma". Am J Surg Pathol 1984;8:655-68. (Pubitemid 14068779)
6. Bonnema SJ, Nielsen VE, Boel-Jorgensen H, Grupe P, Andersen PB, et al. Improvement of goiter volume reduction after 0.3 mg rhTSH-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 2007;92:3424-8. (Pubitemid 47435314)
7. Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 2006;106:1286-95. (Pubitemid 43363905)
8. Varverakis E, Neonakis E. Contribution of high-resolution ultrasonography in the differential diagnosis of benign from malignant thyroid nodules. Hormones (Athens) 2002;1:51-6.
9. Bennedbaek FN, Hegedus L. Management of the solitary thyroid nodule: results of a North American survey. J Clin Endocrinol Metab 2000;85:2493-8. (Pubitemid 32269206)
10. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941-6. (Pubitemid 34521470)
11. Liel Y, Ariad S, Barchana M. Long-term follow-up of patients with initially benign thyroid fine-needle aspirations. Thyroid 2001;11:775-8. (Pubitemid 32762716)
12. Feinmesser R, Lubin E, Segal K, Noyek A. Carcinoma of the thyroid in children - a review. J Pediatr Endocrinol Metab 1997;10:561-8. (Pubitemid 28047362)
13. Landau D, Vini L, A'Hern R, Harmer C. Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer 2000;36:214-20. (Pubitemid 30102198)
14. Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010;22:395-404.
15. Shapiro NL, Bhattacharyya N. Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope 2005;115:337-40. (Pubitemid 40216715)
16. Ito Y, Hirokawa M, Fukushima M, Inoue H, Yabuta T, et al. Prevalence and prognostic significance of poor differentiation and tall cell variant in papillary carcinoma in Japan. World J Surg 2008;32:1535-43; discussion 1544-35.
17. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007;31:1256-64. (Pubitemid 47207131)
18. Sideri M, Jones RW, Heller DS, Haefner H, Neill S, et al. Comment on the article: Srodon M, Stoler MH, Baber GB, et al. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN) Am J Surg Pathol 2006;30:1513-8. Am J Surg Pathol 2007;31:1452; author reply 1452-4. (Pubitemid 47329684)
19. DeLellis R, Lloyd R, Heitz P, Eng C. Pathology and genetics of tumours of endocrine organs, 1st ed. Lyon: IARC Press, 2004.
20. Pilotti S, Collini P, Mariani L, Placucci M, Bongarzone I, et al. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 1997;21:1466-73. (Pubitemid 27528257)
21. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003;88:5399-404. (Pubitemid 37452745)
22. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, et al. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 1993;91:1753-60. (Pubitemid 23127381)
23. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, et al. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 2001;158:987-96. (Pubitemid 32221790)
24. Volante M, Papotti M. Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol 2010;21:1-6.
25. Esapa CT, Johnson SJ, Kendall-Taylor P, Lennard TW, Harris PE. Prevalence of Ras mutations in thyroid neoplasia. Clin Endocrinol (Oxf) 1999;50:529-35. (Pubitemid 29193238)
26. Nikiforov YE. Poorly differentiated carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LD, editors. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Lippincott Williams & Wilkins, 2009:214-27.
27. 131I therapy of thyroid cancer patients. Q J Nucl Med 1999;43:324-35. (Pubitemid 30113561)
28. Lin JD, Chao TC, Hsueh C. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas. Clin Endocrinol (Oxf) 2007;66:224-8. (Pubitemid 46096142)
29. Luster M, Handkiewicz-Junak D, Grossi A, Zacharin M, Taieb D, et al. Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study. J Clin Endocrinol Metab 2009;94:3948-53.